• Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

  • 2024/07/15
  • 再生時間： 9 分
  • ポッドキャスト

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss recent data analyzing the real-world implications of donanemab treatment for people with Alzheimer disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss recent data analyzing the real-world implications of donanemab treatment for people with Alzheimer disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
身体的病い・疾患 衛生・健康的な生活 生物科学
続きを読む 一部表示

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemabに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。